Search clinical trials for: ACTIVA BioACTIVE-RESTORATIVE

Total 10000 results

NEAT ID Foundation
Gilead Sciences

Completed

Study to Evaluate the Clinical Outcomes in Adults With Covid-19 Who Have Been Treated With Remdesivir. (909REM)

Covid19

Spain, United Kingdom, France, Israel, Netherlands
Boehringer Ingelheim

Completed

BI 409306 Cardiac Safety Trial in Healthy Volunteers

Healthy

Germany
University of Washington
National Institute on Aging (NIA)

Completed

Innovations in Dementia Empowerment and Action (IDEA)

Dementia | Alzheimer Disease | Mild Cognitive Impairment | Vascular Dementia | Lewy Body Dementia | Parkinson Disease Dementia

United States
Boehringer Ingelheim

Completed

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of BI 409306

Healthy

Germany
Bayer

Completed

Prospective, Non-interventional, Multi-center, Post-authorization Safety Study of Riociguat for Pulmonary Arterial Hypertension (PAH) (JPMS-PAH)

Hypertension, Pulmonary

Japan
IRCCS San Raffaele

Completed

Neoadjuvant PRRT With 177Lu-DOTATATE Followed by Surgery for Resectable PanNET (NeoLuPaNET)

Neuroendocrine Tumors

Italy
Military Institute of Medicine, Poland

Terminated

Anti-Xa Activity of Enoxaparin for Prevention of Venous Thromboembolism in Severe Nephrotic Syndrome. (ENOX-inNS)

Nephrotic Syndrome

Poland
UNICANCER

Completed

Study on Androgen Receptor and Triple Negative Breast Cancer (START)

Breast Cancer Female | Triple Negative and Androgen Receptor Positive

France
Ottawa Hospital Research Institute
GlaxoSmithKline; Hamilton Health Sciences Corporation; London Regional Cancer... and other collaborators

Completed

A Phase II Window of Opportunity Trial of PRMT5 Inhibitor, GSK3326595, in Early Stage Breast Cancer (OTT-19-06)

Breast Cancer

Canada
Institut National de la Recherche Agronomique

Completed

Bioavailability of Protein and Amino Acids of Pea Protein Isolate in Healthy Volunteers (Qualipois)

Proteins

France
Nerre Therapeutics Ltd.

Completed

A Dose-ranging Study of Orvepitant in Patients With Chronic Refractory Cough

Chronic Refractory Cough

United States, Canada, United Kingdom
Genzyme, a Sanofi Company

Completed

A Dose Confirmation Study of Oral Clofarabine for Adult Patients Previously Treated for Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndromes | Secondary Acute Myeloid Leukemia (AML)

United States
Aalborg University
University of Aarhus; Lundbeck Foundation; Danish National Research Foundation

Terminated

Assessment of the Effects of Extensive Somatosensory Training on Pain Processing

Musculoskeletal Pain

Denmark
University Hospital, Bordeaux
GE Healthcare; Avid Radiopharmaceuticals; Fondation Plan Alzheimer

Completed

Longitudinal Study of Brain Amyloid imaGing in MEMENTO (MEMENTOAmyGing)

Alzheimer's Disease (AD) and Related Disorders

France
Sunnybrook Health Sciences Centre

Completed

Nasal Photodisinfection COVID-19 Proof of Concept Study

COVID-19 | SARS-CoV 2 | Corona Virus Infection

Canada
National Institute of Allergy and Infectious Diseases...

Completed

A Study of Ribavirin in the Treatment of Patients With AIDS and AIDS-Related Problems

HIV Infections

United States
Novartis Pharmaceuticals

Completed

Study of Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-differentiated, Non-functional Neuroendocrine Tumors of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC)

Well-differentiated Non-functional NET of Thoracic Origin | Well-differentiated Non-functional NET of Gastrointestinal Origin | Well-differentiated Non-functional NET of Pancreatic Origin | Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma

United States, Italy, Spain, Japan, Belgium, Netherlands, Germany, France, Canada, Austria, United Kingdom, Australia
Gilead Sciences

Terminated

Roll Over Study to Provide Idelalisib to Participants Previously Treated With the Investigational PI3Kδ Inhibitor, GS-9820

Lymphoid Malignancies

Netherlands
University of Wisconsin, Madison

Completed

Capecitabine Pharmacokinetics(PK)-Actual Versus Ideal Body Weight

Neoplasms | Obesity

United States
Galderma R&D

Completed

Double-Blind Efficacy and Safety of CD5789 (Trifarotene) 50µg/g Cream Versus Vehicle Cream in Acne Vulgaris

Acne Vulgaris

United States, Hungary, Czechia, Poland, Romania, Russian Federation, Spain, Ukraine
Bayer

Completed

A Double-blind Study to Investigate Efficacy, Safety and Tolerability of BAY 1142524 in Patients After Acute Myocardial Infarction With Left-ventricular Dysfunction (CHIARA MIA 2)

Myocardial Infarction

Spain, Germany, Czechia, Israel, Italy
The Netherlands Cancer Institute
Eli Lilly and Company; Universitaire Ziekenhuizen KU Leuven; European Organisation... and other collaborators

Withdrawn

Galunisertib and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer (EORTC1615)

Colorectal Cancer Metastatic

Netherlands
Swiss Group for Clinical Cancer Research

Completed

Capecitabine in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Prostate Cancer

Switzerland
Hospital San Carlos, Madrid
Complexo Hospitalario Universitario de A Coruña

Completed

Standard Versus Continuous Capecitabine in Advanced Breast Cancer

Metastatic Breast Cancer

Spain
Bayer

Completed

Riociguat Clinical Effects Studied in Patients With Insufficient Treatment Response to Phosphodiesterase-5 Inhibitor (RESPITE)

Hypertension, Pulmonary

Belgium, United States, Switzerland, Canada, France, Germany, Italy, United Kingdom, Czechia
Zhejiang Cancer Hospital

Unknown

Capecitabine in the Treatment of Breast Cancer With Low-hormone Receptor Expression After Neoadjuvant Chemotherapy (CALORIE)

Breast Cancer
Eisai Inc.
Eisai Co., Ltd.

Completed

Post-marketing Study of Monteplase ("Cleactor") in Patients With Acute Pulmonary Embolism

Pulmonary Embolism

Japan
American College of Radiology Imaging Network
National Cancer Institute (NCI)

Terminated

FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing Chemotherapy (ACRIN6678)

Lung Cancer

United States
Asan Medical Center

Unknown

PDR001 in Patients With Non-small Cell Lung Cancer Harboring KRAS/NRAS Mutation or no Actionable Genetic Abnormalities

Cancer | Lung Cancer Metastatic | Immunotherapy

Korea, Republic of
University Hospital, Limoges

Terminated

Cardiopulmonary Effects of Bronchoalveolar Wash on Patients With Acute Respiratory Distress Syndrome (FLOOD)

Bronchioalveolar Lavage

France
Qilu Pharmaceutical Co., Ltd.

Unknown

A Bioequivalence Study of Capecitabine Tablets 500 mg in Adult Cancer Patients Under Fed Condition (Capecitabine)

Breast Cancer | Colon Cancer
John Mark Sloan
Gilead Sciences

Terminated

Idelalisib for Immunoglobulin M (IgM)-Associated Primary (AL) Amyloidosis

Amyloidosis

United States
Hennepin Healthcare Research Institute
Aventis Pharmaceuticals

Completed

The Use of Low Molecular Weight Heparin in Traumatic Brain Injury

Brain Injury | Venous Thrombosis

United States
The Catholic University of Korea

Unknown

Phase 3 Study of Xelox Followed by Maintenance Capecitabine in the Advanced Gastric Cancer

Stomach Neoplasms

Korea, Republic of
Bayer

Completed

A Study to Understand the Treatment Patterns in Patients With Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension During a Switch of Treatment to Adempas in Real-life Clinical Practice (CAPTURE)

Hypertension, Pulmonary

Japan, Germany, Sweden, Colombia, Turkey, Belgium, Canada
Samsung Medical Center
Roche Pharma AG

Terminated

Xeloda Maintenance Versus BSC in Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

Korea, Republic of
GlaxoSmithKline

Completed

A Healthy Volunteer Pharmacokinetic Study of Single and Repeat Doses of SB-480848

Atherosclerosis

United States
Hoffmann-La Roche

Completed

A Study of Capecitabine (Xeloda) in Patients With Metastatic Colorectal Cancer

Colorectal Cancer

Bulgaria
West China Hospital

Unknown

Preoperative Administration of Heparin as Thromboprophylaxis in Major Thoracic Surgery

Thoracic Surgery | Thromboprophylaxis

China
Chromaderm, Inc.

Completed

Reduction in the Occurrence of Center-Involved Diabetic Macular Edema

Diabetic Retinopathy

United States, Canada, France, Denmark, Australia, Netherlands, Taiwan, Spain, Italy, Germany, Portugal, United Kingdom, Russian Federation, Poland, India, Brazil, Mexico
Chromaderm, Inc.

Completed

Isoprostane/FMD Study The Effect of Protein Kinase C (PKC) β Specific Inhibitor LY333531 on Oxidant Stress in Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Capecitabine in Treating Patients With Malignant Mesothelioma

Malignant Mesothelioma

United States
Mirati Therapeutics Inc.

Terminated

Study of MGCD0103 (MG-0103) in Patients With Relapsed or Refractory Hodgkin's Lymphoma

Hodgkin's Lymphoma

United States, Canada
Mirati Therapeutics Inc.

Completed

Study of MGCD0103 Given Three Times Weekly in Patients With Relapsed and Refractory Lymphoma

Lymphoma

United States, Canada
Indiana University School of Medicine
Genzyme, a Sanofi Company

Completed

A Phase I Trial of Myeloablative Conditioning w/ Clofarabine and HD Busulfan for Pts w/ Refractory Heme Malignancies Undergoing Allo PBSCT

Hematologic Malignancies

United States
University of Liverpool
Liverpool University Hospitals NHS Foundation Trust

Completed

Dose Response Study of Nitisinone in Alkaptonuria (SONIA1)

Alkaptonuria

United Kingdom
National Cancer Institute (NCI)

Completed

Saracatinib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery

Recurrent Melanoma | Stage IV Melanoma | Stage IIB Melanoma | Stage IIC Melanoma | Stage IIA Melanoma

United States
ThromboGenics

Completed

Safety and Efficacy Study of Microplasmin in for Non-Surgical Treatment of Focal Vitreomacular Adhesion (MIVI-8)

Focal Vitreomacular Adhesion

Belgium
University of Chicago
Genzyme, a Sanofi Company

Completed

Clofarabine Bone Marrow Cytoreduction

Leukemia

United States
Sun Yat-sen University

Unknown

Phase II Study of Maintenance Capecitabine to Treat Resectable Colorectal Cancer (CAMCO)

Colorectal Neoplasms

China

Search clinical trials for: ACTIVA BioACTIVE-RESTORATIVE

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cyprus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations